Pharmacokinetics of Once Daily Antiretroviral Therapy Regimens Containing Tenofovir and Atazanavir/Ritonavir in Adolescents and Young Adults With HIV Infection
Sponsor study identifier
observational
30
2 countries
12
Study Start
February 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2007
Actual (reported)Study Completion
December 2007
Actual (reported)The purpose of this project is to study the pharmacokinetics of a once-daily antiretroviral medication used to treat adolescents and young adults with HIV infection.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2007
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 4, 2006
Actual (reported)January 9, 2006
Actual (reported)February 2006
Date type not reportedThis date has not been verified as actual or estimated.
December 2007
Actual (reported)December 2007
Actual (reported)Measure the pharmacokinetics of atazanavir/ritonavir and tenofovir
To measure the pharmacokinetics of atazanavir/ritonavir and tenofovir when used in combination to treat HIV-infected adolescents and young adult subjects
6 Months
Kinetics comparison
6 Months
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Persons with HIV-1 infection between the ages of 18 years, 0 days and 24 years, 364 days currently on a stable combination antiretroviral regimen (\> 28 days) with FDA-approved antiretroviral combination regimens that include tenofovir plus atazanavir/ritonavir and at least one other active antiretroviral drug.
Children's Hospital of Los Angeles
Los Angeles, California, 90027, United States
University of California at San Diego
San Diego, California, 92103, United States
University of California at San Francisco
San Francisco, California, 94143, United States
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
Children's Diagnostic and Treatment Center
Fort Lauderdale, Florida, 33316, United States
University of Miami
Miami, Florida, 33101, United States
Stroger Hospital of Cook County
Peter Havens, MD
MACC Fund Research Center
First Submitted
January 4, 2006
First Posted
January 9, 2006
Study Start
February 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2007
Actual (reported)Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection
Contact the study team to confirm eligibility.
Chicago, Illinois, 60612, United States
University of Maryland
Baltimore, Maryland, 21201, United States
Children's Hopsital of Boston
Boston, Massachusetts, 02115, United States
Mount Sinai Hospital
New York, New York, 10128, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
University of Puerto Rico
San Juan, 00936, Puerto Rico
Study Completion
December 2007
Actual (reported)Last Updated
February 28, 2017
Record last verified: 2016-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: